SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AtriCure, Inc. (ATRC) (CIK 0001323885) (ATRC) — Aug 2, 2005

AtriCure, Inc. (ATRC) (CIK 0001323885)
Date: Aug. 2, 2005 · CIK: 0001323885 · Accession: 0001193125-05-155181

AI Filing Summary & Sentiment

File numbers found in text: 333-124197

Referenced dates: August 2, 2005

Date
August 2, 2005
Author
Not clearly detected
Form
CORRESP
Company
AtriCure, Inc. (ATRC) (CIK 0001323885)

Letter

Acceleration Letter

Epstein Becker & Green, P.C.

250 Park Avenue

New York, NY 10177

DIRECT:

(212) 351-4522

tpolin@ebglaw.com

August 2, 2005

VIA EDGAR AND FACSIMILE

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attn: Peggy A. Fisher, Assistant Director

Re:

AtriCure, Inc.

Registration Statement on Form S-1

(File No. 333-124197)

Ladies and Gentlemen:

On behalf of AtriCure, Inc. (the “Company”), we are filing, via EDGAR, a letter from the Company requesting that the above-captioned Registration Statement be declared effective at 2:00 p.m., New York time, on the 4th of August 2005, or as soon thereafter as practicable, and a letter from the representatives of the underwriters joining in such request.

With respect to the comment set forth in the staff’s letter, dated August 2, 2005, concerning Exhibit 5.1, we hereby confirm that the reference and limitation to “Delaware General Corporation Law” includes the statutory provisions and also all applicable provisions of the Delaware Constitution and reported judicial decisions interpreting these laws.

Very truly yours,

/S/ THEODORE L. POLIN

Theodore L. Polin

cc: Mary Beth Breslin, Esq. (via facsimile)

202-772-9218

ATRICURE, INC.

6033 Schumacher Park Drive

West Chester, OH 45069

August 2, 2005

VIA EDGAR AND FACSIMILE

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attn: Peggy A. Fisher, Assistant Director

Re:

AtriCure, Inc. (the “Company”)

Registration Statement on Form S-1

(File No. 333-124197)

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated to Thursday, August 4, 2005 at 2:00 pm (New York time), or as soon thereafter as practicable.

The Company acknowledges that:

ð should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

ð the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

ð the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Signature page follows

August 2, 2005

Page 2

Very truly yours,
ATRICURE, INC.

Show Raw Text
CORRESP
1
filename1.htm

Acceleration Letter

 Epstein Becker & Green, P.C.

 250 Park Avenue

 New York, NY 10177

 DIRECT:

 (212)
351-4522

 tpolin@ebglaw.com

August 2, 2005

 VIA EDGAR AND FACSIMILE

 Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn:  Peggy A. Fisher, Assistant Director

                Re:

 AtriCure, Inc.

 Registration Statement on Form
S-1

 (File No.
333-124197)

 Ladies and Gentlemen:

 On behalf of AtriCure, Inc. (the “Company”), we are filing, via
EDGAR, a letter from the Company requesting that the above-captioned Registration Statement be declared effective at 2:00 p.m., New York time, on the 4th of August 2005, or as soon thereafter as practicable, and a letter from the representatives of
the underwriters joining in such request.

 With respect to the
comment set forth in the staff’s letter, dated August 2, 2005, concerning Exhibit 5.1, we hereby confirm that the reference and limitation to “Delaware General Corporation Law” includes the statutory provisions and also all applicable
provisions of the Delaware Constitution and reported judicial decisions interpreting these laws.

 Very truly yours,

 /S/  THEODORE L. POLIN

 Theodore L. Polin

cc:
Mary Beth Breslin, Esq. (via facsimile)

202-772-9218

 ATRICURE, INC.

 6033 Schumacher Park Drive

 West Chester, OH 45069

 August 2, 2005

 VIA EDGAR
AND FACSIMILE

 Securities and Exchange Commission

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn:    Peggy A. Fisher, Assistant Director

 Re:

 AtriCure, Inc. (the “Company”)

 Registration Statement on Form S-1

 (File No.
333-124197)

 Ladies and Gentlemen:

 Pursuant to Rule 461 of the Rules and Regulations promulgated under the
Securities Act of 1933, as amended, the undersigned hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated to Thursday, August 4, 2005 at 2:00 pm (New York
time), or as soon thereafter as practicable.

 The Company
acknowledges that:

ð
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to
the filing;

ð
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

ð
the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States.

 Signature page follows

 August 2, 2005

 Page 2

 Very truly yours,

 ATRICURE, INC.

 By:
/s/    Thomas Etergino

 Thomas J. Etergino

 Vice President and

 Chief Financial Officer

 cc: Mary Beth Breslin,
Esq. (202) 772-9218